Comparing two medicines to prevent heavy bleeding after planned cesarean
Treatments studied
Part of Women’s health & pregnancy clinical trials.
This study compares two medicines—carbetocin and oxytocin—given during a planned cesarean to help prevent heavy bleeding after delivery. It is for women who have certain risk factors for uterine atony (when the uterus does not tighten up after birth).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled for a planned (elective) cesarean section.
- You have at least one of the following risk factors: a larger than normal uterus (from too much amniotic fluid, a big baby, or multiple babies), a history of heavy bleeding after a previous birth, obesity with a BMI over 40, diabetes or high blood pressure on medication, or placenta previa.
- You do not have any heart valve problems, irregular heartbeat, or heart failure.
- You do not have placenta accreta (a condition where the placenta grows too deeply).
- You do not have a bleeding disorder or severe anemia (hemoglobin below 100 g/L).
- You are not allergic to oxytocin or carbetocin.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two doses of oxytocin (a medicine given during cesarean section to prevent heavy bleeding) to see which works better for women with high-risk pregnancies. If you are having a planned cesarean and have certain risk factors, this trial may help find the best dose for you.
This trial tests whether giving a specific combination of three medicines during a planned c-section is better than one medicine alone for preventing postpartum hemorrhage (heavy bleeding after birth).
This study compares two medications (tranexamic acid and oxytocin) given directly into the uterus during a planned cesarean section to see which works better at reducing blood loss. It is for women with a single, full-term pregnancy and no major health complications.
This trial tests a new way to give oxytocin—a tablet placed under the tongue—right after the baby is born, to prevent dangerous heavy bleeding. If it works, it could be a simple, needle-free option for mothers everywhere.
This trial studies whether tranexamic acid, a medicine that helps blood clot, can prevent postpartum hemorrhage (heavy bleeding after delivery) in people having a planned C-section or likely vaginal delivery after 34 weeks. It may help lower the risk of dangerous bleeding around the time of birth.
This study looks at how oxytocin (a medicine often used to help with labor and uterine contractions) moves through the body and what it does during a non-emergency C-section. It may help improve how oxytocin is used in the future for safer, more predictable delivery care.
Hear when a new Post Partum Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.